S-ROM*LINR LSER,10 DEG,22.225
Report
- Report Number
- 1818910-2013-19928
- Event Type
- Injury
- Date Received
- June 26, 2013
- Date of Event
- June 24, 2013
- Report Date
- June 25, 2013
- Manufacturer
- DEPUY ORTHOPAEDICS INC
- Product Code
- KWA
- PMA / PMN Number
- PK924492
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
Narratives
THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.
EXAMINATION OF THE REPORTED DEVICES WAS NOT POSSIBLE AS THEY WERE NOT RETURNED. A SEARCH OF THE COMPLAINTS DATABASES AND/OR A REVIEW OF DEVICE HISTORY RECORDS WERE NOT POSSIBLE AS THE REQUIRED PRODUCT/LOT CODE COMBINATIONS WERE NOT PROVIDED. REVIEW OF PROVIDED PATIENT X-RAYS FINDS THE HEAD IS NOT CENTERED IN THE CUP AND MAY HAVE SHIFTED SUPERIORLY. THIS COULD INDICATE POLY WEAR OF THE LINER AS MENTIONED IN THE COMPLAINT. THE PATIENT IS A REPORTED 62 Y/O MALE AT 107 KG AND 6 FEET TALL. CALCULATED BMI IS 32. THE PATIENT IS CONSIDERED OBESE. THE WEIGHT OF THE PATIENT EXCEEDS THE PROSTHESIS RECOMMENDATIONS. THERE ARE WARNINGS AGAINST IMPROPER PROSTHESIS SELECTION OR ALIGNMENT THAT TEND TO ADVERSELY AFFECT HIP REPLACEMENT IMPLANTS INCLUDING EXCESSIVE PATIENT WEIGHT. THE INVESTIGATION CAN DRAW NO CONCLUSION REGARDING THE REPORTED EVENT WITH THE INFORMATION AVAILABLE. BASED ON THE INABILITY TO DETERMINE ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION HAS NOT BEEN INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.
THE PATIENT PRESENTED WITH PAIN. X-RAYS SHOWED POLYETHYLENE LINER WEAR. THE POLYETHYLENE LINER WAS WORN, WITH EVIDENCE OF POLYETHYLENE DISEASE (LYSIS).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 291175 | S-ROM*LINR LSER,10 DEG,22.225 | ACETABULAR LINER | KWA | DEPUY ORTHOPAEDICS INC | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Required Intervention |